Capital International Investors’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CS
AC
SCM
Capital International Investors's BLUE Position: Q1 2021 in Review
Capital International Investors sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 87,057 shares — an estimated $48.8M sold.
Capital International Investors first reported a position in BLUE in Q1 2018 and held it in 12 quarters. The position peaked at $806M in Q1 2019. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.
- Capital International Investors reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
- Capital International Investors sold 87,057 bluebird bio shares in Q1 2021, an estimated $48.8M.
- Capital International Investors first reported a position in bluebird bio in Q1 2018 and held it in 12 quarters.
- Capital International Investors's bluebird bio position peaked at $806M in Q1 2019.
- 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.
Based on Capital International Investors's 13F filing for Q1 2021, filed 14 May 2021.